sodium salicylate has been researched along with misoprostol in 2 studies
| Studies (sodium salicylate) | Trials (sodium salicylate) | Recent Studies (post-2010) (sodium salicylate) | Studies (misoprostol) | Trials (misoprostol) | Recent Studies (post-2010) (misoprostol) |
|---|---|---|---|---|---|
| 2,031 | 50 | 171 | 4,611 | 1,522 | 1,686 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramson, SB; Kitsis, EA; Weissmann, G | 1 |
| Albrecht, M; Brandt, KD; O'Bryan-Tear, G | 1 |
2 other study(ies) available for sodium salicylate and misoprostol
| Article | Year |
|---|---|
The prostaglandin paradox: additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol.
Topics: Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcimycin; Calcium; Cell Aggregation; Cyclic AMP; Depression, Chemical; Drug Synergism; Glucuronidase; Humans; Indomethacin; Misoprostol; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Prostaglandins; Sodium Salicylate; Superoxides; Tetradecanoylphorbol Acetate | 1991 |
Misoprostol does not protect articular cartilage from salicylate-induced suppression of proteoglycan synthesis.
Topics: Alprostadil; Animals; Aspirin; Cartilage, Articular; Cells, Cultured; Culture Media; Dogs; Glycosaminoglycans; Humerus; Misoprostol; Salicylates; Salicylic Acid; Sodium Salicylate | 1991 |